Contents
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued), Volume 1 - Number 2
Editorial
Editorial (Thematic Issue: Idiopathic Pulmonary Fibrosis)
, 1(2): 1 - 2Dra Glenda Ernst
DOI: 10.2174/221270380102150520120958
Interstitial Lung Disease Associated with Collagen Vascular Disease
, 1(2): 69 - 78Marco Antonio Solis Aramayo and Antonio Lopez Lopez
DOI: 10.2174/2212703801666150520110551
Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
, 1(2): 79 - 86Juan I. Enghelmayer, Tulio Papucci and Alejandro Raimondi
DOI: 10.2174/221270380102150520111811
Idiopathic Pulmonary Fibrosis: Treatment Strategies
, 1(2): 87 - 94Brenda E. Varela and Gabriela C. Tabaj
DOI: 10.2174/221270380102150520112938
Idiopathic Pulmonary Fibrosis, Opportunities and Challenges
, 1(2): 95 - 98Glenda Ernst, Borsini Eduardo and Salvado Alejandro
DOI: 10.2174/2212703802666150127002032
Randomized, Placebo Controlled Study of the Effects of Etoricoxib on Markers of Inflammation, Pain and Muscle Force After Eccentric Exercise
, 1(2): 99 - 110Matthias Rother, Egbert Johannes Seidel, Ilka Rother and Steffen Koll
DOI: 10.2174/221270380102150520115507
Effect of Early Treatment of Newborns by Peroral Colonization Using Non-pathogenic E. coli on the Development of Their Immuno- allergic System
, 1(2): 111 - 121Jiri Liska, Konrad Siala, Vaclav Holecek, Stepanka Sobotova, Monika Kepkova and RNDr. Ing. Frantisek Sefrna
DOI: 10.2174/2212703802666150127001859
Comparison of In Vitro and In Vivo Effects of Infliximab on Cytokine Production in Proliferating CD4+ T Cells in Patients with Rheumatoid Arthritis
, 1(2): 122 - 128Syuichi Koarada, Yuri Sadanaga, Natsumi Nagao, Satoko Tashiro, Rie Suematsu, Akihide Ohta and Yoshifumi Tada
DOI: 10.2174/2212703802666150127001412
Pharmacological Screening of Lantana camara for its Antiallergic Activity in Rodents
, 1(2): 129 - 136Manojkumar Mahajan, Vishal Gulecha and Chandrashekhar Upasani
DOI: 10.2174/221270380102150520120102
Webmaster Contact: info@benthamscience.org